Evidence map›Paper›PMID 32908144›Full record

ArticleNature communications2020

Antibiotic susceptibility signatures identify potential antimicrobial targets in the Acinetobacter baumannii cell envelope.

Edward Geisinger, Nadav J Mortman, Yunfei Dai, Murat Cokol, Sapna Syal, Andrew Farinha, Delaney G Fisher, Amy Y Tang, David W Lazinski, Stephen Wood and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Control of cell division by anbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Large-scale combination screens reveal small-molecule sensitization of antibiotic-resistant gram-negative ESKAPE pathogens.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Perturbation-specific transcriptional mapping for unbiased target elucidation of antibiotics.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Edward GeisingerDepartment of Biology, Northeastern University, Boston, MA, 02115, USA. e.geisinger@northeastern.edu.ORCID http://orcid.org/0000-0001-9661-8072
Nadav J MortmanDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, 02111, USA.
Yunfei DaiDepartment of Biology, Northeastern University, Boston, MA, 02115, USA.
Murat CokolDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, 02111, USA.ORCID http://orcid.org/0000-0001-9084-3367
Sapna SyalDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, 02111, USA.
Andrew FarinhaDepartment of Biology, Northeastern University, Boston, MA, 02115, USA.
Delaney G FisherDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, 02111, USA.ORCID http://orcid.org/0000-0002-1876-4733
Amy Y TangDepartment of Biology, Northeastern University, Boston, MA, 02115, USA.
David W LazinskiDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, 02111, USA.
Stephen WoodBiology Department, Boston College, Chestnut Hill, MA, 02467, USA.
Jon AnthonyBiology Department, Boston College, Chestnut Hill, MA, 02467, USA.
Tim van OpijnenBiology Department, Boston College, Chestnut Hill, MA, 02467, USA.ORCID http://orcid.org/0000-0001-6895-6795
Ralph R IsbergDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA, 02111, USA. ralph.isberg@tufts.edu.ORCID http://orcid.org/0000-0002-8330-3554
Tufts University · USBoston College · USNortheastern University · US

Funding

Predicting the emergence of antibiotic resistance through multi-omics approaches and Immune System-surveillanU01AI124302 · NIAID · BOSTON COLLEGE · PI BENTO, JOSE, COOPER, VAUGHN · 2016 to 2020
$10.2M
Identification of the Achilles’ heel in Acinetobacter fluoroquinolone-resistant mutantsR21AI128328 · NIAID · TUFTS UNIVERSITY BOSTON · PI ISBERG, RALPH R. · 2017 to 2018
$454k
Type VI Protein Secretion in an Emerging Multidrug-Resistant PathogenF32AI098358 · NIAID · TUFTS UNIVERSITY BOSTON · PI GEISINGER, EDWARD · 2012 to 2014
$168k
NIAID NIH HHS F32 AI098358NIAID NIH HHS R21 AI128328NIAID NIH HHS U01 AI124302
6 · The paper itself

Abstract

A unique, protective cell envelope contributes to the broad drug resistance of the nosocomial pathogen Acinetobacter baumannii. Here we use transposon insertion sequencing to identify A. baumannii mutants displaying altered susceptibility to a panel of diverse antibiotics. By examining mutants with antibiotic susceptibility profiles that parallel mutations in characterized genes, we infer the function of multiple uncharacterized envelope proteins, some of which have roles in cell division or cell elongation. Remarkably, mutations affecting a predicted cell wall hydrolase lead to alterations in lipooligosaccharide synthesis. In addition, the analysis of altered susceptibility signatures and antibiotic-induced morphology patterns allows us to predict drug synergies; for example, certain beta-lactams appear to work cooperatively due to their preferential targeting of specific cell wall assembly machineries. Our results indicate that the pathogen may be effectively inhibited by the combined targeting of multiple pathways critical for envelope growth.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsBacterial ProteinsCell WallCross InfectionDNA, BacterialDNA Mutational AnalysisDNA Transposable ElementsDrug Resistance, Multiple, BacterialDrug SynergismHumansMicrobial Sensitivity TestsMutationAnti-Bacterial AgentsBacterial ProteinsDNA, BacterialDNA Transposable Elements

Identifiers

PMID32908144
PMCPMC7481262
OpenAlexW3083784660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.